Chalcones incorporated pyrazole ring inhibit proliferation, cell cycle progression, angiogenesis and induce apoptosis...

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Cancer Biology

Background:

• Chalcone derivatives are known for diverse biological activities.
• Pyrazole-containing compounds have shown promise in medicinal applications.
• Targeting cancer cell proliferation and apoptosis is crucial for effective treatment.

Purpose of the Study:

• To synthesize and evaluate the cytotoxicity of novel pyrazole chalcone derivatives.
• To investigate the molecular mechanisms underlying the anticancer effects of lead compounds.
• To explore the potential of these derivatives as therapeutic agents for breast cancer.

Main Methods:

• Synthesis of chalcone derivatives incorporating a pyrazole ring.
• In vitro cytotoxicity assays against human breast (MCF-7), colon (HCT-116), and liver (HEPG2) cancer cell lines, and normal melanocyte (HFB4) cells.
• Detailed molecular studies on MCF-7 cells, including proliferation, angiogenesis, cell cycle, and apoptosis assays.

Main Results:

• Several chalcone derivatives exhibited significant cytotoxicity against cancer cell lines.
• Two selected compounds effectively inhibited proliferation, angiogenesis, and cell cycle progression in MCF-7 cells.
• Apoptosis induction was observed, mediated by the upregulation of tumor suppressor p53 and S-G2/M cell cycle arrest.

Conclusions:

• The novel pyrazole chalcone derivatives possess potent antitumor activity.
• These compounds demonstrate a clear mechanism of action against breast cancer cells.
• The findings support the development of these chalcones as potential new anticancer agents.